Teva Pharmaceutical Industries Limited (TEVA) SEC filings
Every SEC filing by Teva Pharmaceutical Industries Limited (CIK 0000818686) in the last two years, with each form explained in plain English and links to the SEC's copies. Industry: Pharmaceutical Preparations. TEVA stock report · earnings · news
Annual & quarterly reports
- 2026-11-03 · 10-Q Quarterly report · document
- 2026-07-29 · 10-Q Quarterly report · document
- 2026-04-29 · 10-Q Quarterly report · document
- 2026-02-03 · 10-K Annual report · document
- 2025-11-05 · 10-Q Quarterly report · document
- 2025-07-30 · 10-Q Quarterly report · document
- 2025-05-07 · 10-Q Quarterly report · document
- 2025-02-05 · 10-K Annual report · document
Major events
- 2026-11-18 · 8-K Executive or director change · Regulation FD disclosure · document
- 2026-11-03 · 8-K Earnings results · document
- 2026-10-29 · 8-K Executive or director change · document
- 2026-09-16 · 8-K New material agreement · New debt or obligation · document
- 2026-09-14 · 8-K Other event · document
- 2026-09-11 · 8-K Regulation FD disclosure · Other event · document
- 2026-09-03 · 8-K Other event · document
- 2026-09-03 · 8-K Change to shareholder rights · document
- 2026-07-29 · 8-K Earnings results · document
- 2026-05-28 · 8-K Shareholder vote results · document
- 2026-04-29 · 8-K Earnings results · Regulation FD disclosure · document
- 2026-01-28 · 8-K Earnings results · document
- 2026-01-12 · 8-K Earnings results · document
- 2025-12-11 · 8-K New material agreement · New debt or obligation · document
- 2025-11-05 · 8-K Earnings results · document
- 2025-07-30 · 8-K Earnings results · document
- 2025-06-05 · 8-K Shareholder vote results · document
- 2025-05-28 · 8-K New material agreement · New debt or obligation · document
- 2025-05-22 · 8-K Regulation FD disclosure · Other event · document
- 2025-05-07 · 8-K Earnings results · document
- 2025-01-29 · 8-K Earnings results · document
Big shareholders
- 2026-11-16 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-11-10 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-11-02 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2026-02-17 · SCHEDULE 13G Over 5% stake, passive investor · document
- 2026-02-09 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2025-11-05 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2025-10-06 · SCHEDULE 13G Over 5% stake, passive investor · document
- 2025-08-06 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
- 2025-07-22 · SCHEDULE 13G Over 5% stake, passive investor · document
- 2025-07-17 · SCHEDULE 13G Over 5% stake, passive investor · document
- 2025-02-12 · SCHEDULE 13G/A Over 5% stake, passive investor (amended) · document
Proxy & votes
- 2026-03-31 · DEFA14A Additional proxy material · document
- 2026-03-31 · DEF 14A Proxy statement (annual meeting, pay, votes) · document
- 2025-04-09 · DEFA14A Additional proxy material · document
- 2025-04-09 · DEF 14A Proxy statement (annual meeting, pay, votes) · document
Offerings & registrations
- 2026-09-11 · 424B5 Prospectus supplement · document
- 2026-09-10 · FWP Free writing prospectus · document
- 2026-09-10 · FWP Free writing prospectus · document
- 2026-09-08 · 424B5 Prospectus supplement · document
- 2025-05-22 · 424B5 Prospectus supplement · document
- 2025-05-20 · FWP Free writing prospectus · document
- 2025-05-19 · 424B5 Prospectus supplement · document
214 insider filings (Forms 3, 4, 5 and 144) in the same period.
Filings link to sec.gov. Research data, not investment advice. Latest SEC filings